Role and Timing of Hematopoietic Cell Transplantation for Myelodysplastic Syndrome

Allogeneic hematopoietic cell transplantation (HCT) is the only curative treatment for patients with myelodysplastic syndromes (MDS). Most patients with MDS are older than 60 years and age-associated morbidities limit the patients’ options for curative transplant therapy. Since the development of co...

Descripción completa

Detalles Bibliográficos
Autores principales: Field, Teresa, Anasetti., Claudio
Formato: Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2010
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033135/
https://www.ncbi.nlm.nih.gov/pubmed/21415970
http://dx.doi.org/10.4084/MJHID.2010.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033135/
https://www.ncbi.nlm.nih.gov/pubmed/21415970
http://dx.doi.org/10.4084/MJHID.2010.019

Ejemplares similares